Lupin share price has zoomed 4% and is presently trading at Rs 1,986.8.
Meanwhile, the BSE HEALTHCARE index is at 40,493.5 (up 1.2%).
Among the top gainers in the BSE HEALTHCARE index today are AJANTA PHARMA (up 4.3%) and Natco Pharma (up 4.3%).
GLAND PHARMA (down 3.1%) and Jubilant Pharmova (down 1.4%) are among the top losers today.
Over the last one year, Lupin has moved up from Rs 1,081.4 to Rs 1,986.8, registering a gain of Rs 905.4 (up 83.7%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,300.0 to 40,493.5, registering a gain of 43.1% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 113.2%), GRANULES INDIA (up 105.6%) and GSK Pharma (up 104.1%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 79,232.0 (up 0.8%).
The top gainers among the BSE Sensex today are M&M (up 2.1%) and MUNDRA PORT & SEZ (up 2.0%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 24,216.1 (up 0.9%). ONGC and Coal India are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,953.5 to 79,232.0, registering a gain of 13,278.5 points (up 20.1%).
Lupin net profit grew 77.7% YoY to Rs 8,055 million for the quarter ended June 2024, compared to a profit of Rs 4,533 million a year ago. Net sales rose 16.3% to Rs 56,003 million during the period as against Rs 48,141 million in April-June 2023.
For the year ended March 2024, Lupin reported 332.3% increase in net profit to Rs 19,356 million compared to net profit of Rs 4,477 million during FY23. Revenue of the company grew 20.2% to Rs 200,108 million during FY24.
The current Price to earnings ratio of Lupin, based on rolling 12 month earnings, stands at 39.6.
Equitymaster requests your view! Post a comment on "Lupin Gains 4%; BSE HEALTHCARE Index Up 1.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!